Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study. (academic.oup.com)

Authors: Landovitz RJ … Plank RM Journal: Clinical Infectious Diseases Published: 2026-03-14 DOI: https://doi.org/10.1093/cid/ciag171